EUVIMEDEUVIMED entdecken
EvaluationsstudieMultizentrische StudieOpen Access · CC BY 4.0

Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel

Muneyori Okita iD, Kento Takenaka, Fumihito Hirai, Shinya Ashizuka, Hideki Iijima, Shigeki Bamba, Toshimitsu Fujii, Kenji Watanabe, Yosuke Shimodaira, Hisashi Shiga, Sakiko Hiraoka, Toshihiro Inokuchi und 3 weitere

Journal of Gastroenterology · 2025

DOI: 10.1007/s00535-025-02223-1 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Journal of Gastroenterology, 2025. Verfasst von Muneyori Okita und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi, 466-8550, Japan. muneyoriokita@gmai…. Hauptthemen laut MEDLINE: Crohn Disease, Glycoproteins, Intestine, Small. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Labor Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labor and Welfare of Japan., Nagoya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Small bowel (SB) lesions in Crohn’s disease (CD) are often asymptomatic despite being highly active. Fecal calprotectin (FC) is the most widely used biomarker of CD activity, but its drawbacks include a large intra-individual sample variability and the burden of collecting stool samples. Meanwhile, serum leucine-rich alpha-2 glycoprotein (LRG) has recently attracted attention as a biomarker that can address the limitations of FC. This study determined the diagnostic accuracy of LRG and its cut-off values for diagnosing CD activity in SB.

Methods

This was a retrospective, multi-center study of CD patients undergoing retrograde balloon-assisted endoscopy. For ileal- and ileocolonic-type patients with a colon SES-CD score of 0, we estimated the receiver operating characteristic curve of LRG and determined the cut-off value to achieve a target sensitivity level of 80%.

Results

Among 285 patients with SB lesions, LRG had an area under the curve (AUC) of 0.72 (95% CI 0.67–0.78) with a sensitivity of 80.2% and specificity of 47.2% for a cut-off value of 10.5 when diagnosing endoscopic remission (modified SES-CD ≤ 3), while it had an AUC of 0.72 (95% CI 0.65–0.78) with a sensitivity of 81.2% and specificity of 46.2% for a cut-off value of 10.1 when diagnosing complete ulcer healing (modified SES-CD ≤ 1).

Conclusion

LRG was effective for diagnosing CD activity in SB, specifically with cut-off values of 10.5 and 10.1 for endoscopic remission and complete ulcer healing, respectively. A future prospective validation study will assess its clinical utility. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseGlycoproteinsIntestine, SmallAdultAgedFemaleHumansMaleMiddle AgedYoung AdultArea Under CurveBiomarkersLeukocyte L1 Antigen ComplexRetrospective StudiesROC CurveSensitivity and SpecificitySeverity of Illness Index

Stichwörter der Autor:innen

BiomarkerCrohn’s diseaseLRG

Substanzen

BiomarkersGlycoproteinsLeukocyte L1 Antigen ComplexLRG1 protein, human

Autor:innen und Institutionen

  • Department of Biostatistics, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, Aichi, 466-8550, Japan. muneyoriokita@gmail.com.
  • Department of Gastroenterology and Hepatology, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
  • Osaka International Medical & Science Center, Osaka Keisatsu Hospital, Osaka, Japan.
  • Department of Fundamental Nursing, Shiga University of Medical Science, Shiga, Japan.
  • Department of Internal Medicine for Inflammatory Bowel Disease, Toyama University, Toyama, Japan.

ORCID-Profile: Muneyori Okita

Förderung

  • Health and Labor Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labor and Welfare of Japan.
  • Nagoya University

Zitieren

APA

Okita, M., Takenaka, K., Hirai, F., Ashizuka, S., Iijima, H., Bamba, S., Fujii, T., Watanabe, K., Shimodaira, Y., Shiga, H., Hiraoka, S., Inokuchi, T., Yamamura, T., Emoto, R., & Matsui, S. (2025). Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel. Journal of Gastroenterology. https://doi.org/10.1007/s00535-025-02223-1

Vancouver

Okita M, Takenaka K, Hirai F, Ashizuka S, Iijima H, Bamba S, et al. Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel. Journal of Gastroenterology. 2025. doi:10.1007/s00535-025-02223-1

BibTeX
@article{Okita2025,
  author = {Okita, Muneyori and Takenaka, Kento and Hirai, Fumihito and Ashizuka, Shinya and Iijima, Hideki and Bamba, Shigeki and Fujii, Toshimitsu and Watanabe, Kenji and Shimodaira, Yosuke and Shiga, Hisashi and Hiraoka, Sakiko and Inokuchi, Toshihiro and Yamamura, Takeshi and Emoto, Ryo and Matsui, Shigeyuki},
  title = {Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel},
  journal = {Journal of Gastroenterology},
  year = {2025},
  doi = {10.1007/s00535-025-02223-1}
}
Kostenlos starten →